Your Source for Venture Capital and Private Equity Financings

Massinvestor/VC News Daily

VC-funded Company:

Elucida Oncology
1 Deer Park Drive, Suite E
Monmouth Junction, NJ 08852
https://www.elucidaoncology.com/

Elucida Oncology is a biotechnology company pioneering the next frontier in targeted cancer therapy with its first-in-class, ultra-small C'Dot drug delivery platform. The company's C'Dot-Drug-Conjugates, or CDCs, are novel therapeutics formulated to substantially increase the concentration of highly potent drugs in difficult to treat tumors with minimal systemic exposure due to their unique Target or Clear™ properties. CDCs are designed to enable precise tumor targeting and deep tumor penetration resulting in enhanced efficacy with reduced off-target toxicity, thereby addressing the limitations of antibody-drug-conjugates and more traditional drug carriers.

Key Contact
Name
Geno Germano
Title
President & CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
01/12/21 $44,000,000 Series A-1